ArticleFrontiers in cellular neuroscience2026
Deletion of
Josiah D Walsh, Diego Scala-Chavez, Andrew S Lee, Arlene Martínez-Rivera, Anjali M Rajadhyaksha
Abstract read
In one paragraphArticle in Frontiers in cellular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Josiah D Walsh *Center for Substance Abuse Research, Department of Neural Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Diego Scala-Chavez *Division of Pediatric Neurology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States.
Andrew S LeeNeuroscience Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, United States.
Arlene Martínez-RiveraCenter for Substance Abuse Research, Department of Neural Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Anjali M RajadhyakshaCenter for Substance Abuse Research, Department of Neural Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MCircuit and Synaptic Mechanisms of Endocannabinoid-Opioid CrosstalkR01DA054368 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Francis Sang Yong Lee, Anjali M Rajadhyaksha · 2022 to 2026
$3.5MInvestigating the mechanistic contribution of Cav1.2 channels in extinction of cocaine-associated memoriesR01DA053261 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Anjali M Rajadhyaksha · 2022 to 2026
$2.6MGABAergic Interneuron Dysfunction in Developing Cortical Circuits Underlying Autism Spectrum DisordersR01MH125006 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE MARCO GARCIA, NATALIA VANESA, RAJADHYAKSHA, ANJALI M · 2021 to 2025
$2.1MNCI NIH HHS P30 CA008748NIDA NIH HHS R01 DA053261NIDA NIH HHS R01 DA054368NIMH NIH HHS R01 MH125006
6 · The paper itselfAbstract
Dopamine signaling is critical for cognitive and emotional regulation and is implicated in multiple neuropsychiatric disorders. One downstream effector of dopamine is the L-type calcium channel CaV1.2, encoded by the risk gene
Indexed as
Cacna1cCaV1.2dopamine 1 receptor (D1)memorysex-differences
Identifiers
PMID42028275
PMCPMC13099333
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390